Anteo Diagnostics Ltd (ADO)

Sydney
0.110
-0.005(-4.35%)
  • Volume:
    607,115
  • Bid/Ask:
    0.110/0.115
  • Day's Range:
    0.110 - 0.120

ADO Overview

Prev. Close
0.115
Day's Range
0.11-0.12
Revenue
720K
Open
0.115
52 wk Range
0.085-0.415
EPS
0
Volume
607,115
Market Cap
228.57M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
11,237,391
P/E Ratio
-
Beta
1.19
1-Year Change
-66.67%
Shares Outstanding
1,987,524,802
Next Earnings Date
28 Aug 2022
What is your sentiment on Anteo Diagnostics?
or
Vote to see community's results!

Anteo Diagnostics Ltd News

Anteo Diagnostics Ltd Company Profile

Anteo Diagnostics Ltd Company Profile

AnteoTech Limited is an Australia-based surface chemistry company. The Company is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The Company's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The Company's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The Company is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsNeutralSellSellBuyStrong Sell
SummaryNeutralNeutralNeutralNeutralStrong Sell
  • This is just the beginning
    0
    • I can see the price for these guys going over $1 in the future if not alot higher if they pull off what they are doing
      2
      • 16/7/2020 Company ASX Announcement regarding Quantitative Multiplex Covid-19 / Flu A / B Test. Next phase of development including clinical studies will take 6-9 months Regulatory approvals / registrations required prior to market launch
        0